FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for magnetic resonance diagnostics of oncological diseases. That is ensured by introducing a diagnostic preparation containing a deuterated sarcosine derivative and/or a pharmaceutically acceptable salt thereof. Deuterated derivative is a compound containing deuterium bonded to a carbon atom in an amount greater than its natural content in at least one position. Also presented is a diagnostic technique for oncological diseases.
EFFECT: group of inventions enables diagnosing oncologic diseases with high information value.
24 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR MAGNETIC RESONANCE IMAGING CONTAINING DEUTERATED NATURAL AMINO ACID WITH BRANCHED SIDE CHAIN, AND DIAGNOSTIC TECHNIQUE USING SAID PREPARATION | 2018 |
|
RU2738850C2 |
| PREPARATION FOR MAGNETIC-RESONANCE DIAGNOSTICS OF F CANCEROUS DISEASES COMPRISING DEUTERATED 2-AMINO-2-METHYLPROPIONIC ACID AND/OR 2-(N-METHYLAMINO)-2-METHYLPROPIONIC ACID AND A DIAGNOSTIC METHOD USING THE PREPARATION | 2017 |
|
RU2663286C1 |
| PREPARATION FOR MAGNETIC RESONANCE DIAGNOSTICS OF ONCOLOGICAL DISEASES CONTAINING DEUTERATED 3-O-METHYLGLUCOSE, AND DIAGNOSTIC METHOD USING SAID PREPARATION | 2017 |
|
RU2718052C2 |
| COMPOUND FOR DIAGNOSING TUMOURS EXPRESSING PSMA AND COMPOSITION BASED THEREON | 2019 |
|
RU2730507C1 |
| MAGNETIC RESONANT AND X-RAY CONTRAST AGENT, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497546C1 |
| METHOD OF DIAGNOSTICS OF ONCOLOGIC DISEASES IN EXPERIMENT | 2007 |
|
RU2343828C2 |
| DEUTERATED HETEROCYCLIC COMPOUNDS AND USE THEREOF AS IMAGING MEANS | 2015 |
|
RU2696492C2 |
| DEUTERATED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IMAGING TOOLS | 2015 |
|
RU2791900C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DISEASES IN PARANASAL SINUSES | 2001 |
|
RU2210308C2 |
| MAGNETIC RESONANT AND RADIOPAQUE CONTRAST AGENT BASED ON COMPLEX FERRIC OXIDE AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2419454C1 |
